Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Jul;100(3):605–613. doi: 10.1111/j.1476-5381.1990.tb15854.x

The action of diazoxide and minoxidil sulphate on rat blood vessels: a comparison with cromakalim.

D T Newgreen 1, K M Bray 1, A D McHarg 1, A H Weston 1, S Duty 1, B S Brown 1, P B Kay 1, G Edwards 1, J Longmore 1, J S Southerton 1
PMCID: PMC1917770  PMID: 2167738

Abstract

1. The actions of diazoxide and minoxidil sulphate have been compared with those of cromakalim in rat aorta and portal vein. 2. Diazoxide and minoxidil sulphate hyperpolarized the rat portal vein in a similar manner to cromakalim. 3. Cromakalim, diazoxide and minoxidil sulphate increased 42K and 86Rb efflux from rat portal vein, although minoxidil sulphate had only a small effect on 86Rb efflux. 4. Cromakalim, diazoxide and minoxidil sulphate increased 42K efflux from rat aorta but only cromakalim and diazoxide increased 86Rb efflux from this tissue. 5. Glibenclamide inhibited the relaxant actions of cromakalim, diazoxide and minoxidil sulphate on rat aorta and the increase in 42K efflux produced by these agents in this tissue. 6. Diazoxide relaxed an 80 mM KCl-induced contraction of rat aorta, whilst cromakalim and minoxidil sulphate were without effect. 7. Cromakalim, diazoxide and minoxidil sulphate had no effect on cyclic AMP or cyclic GMP concentrations in rat aorta. 8. It is concluded that diazoxide and minoxidil sulphate like cromakalim exhibit K+ channel opening properties in vascular smooth muscle. Diazoxide exerts an additional inhibitory action not related to the production of cyclic AMP or cyclic GMP. The action of minoxidil sulphate may be primarily located at a K+ channel which is relatively impermeable to 86Rb.

Full text

PDF
608

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allen S. L., Beech D. J., Foster R. W., Morgan G. P., Small R. C. Electrophysiological and other aspects of the relaxant action of isoprenaline in guinea-pig isolated trachealis. Br J Pharmacol. 1985 Dec;86(4):843–854. doi: 10.1111/j.1476-5381.1985.tb11106.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ashwood V. A., Buckingham R. E., Cassidy F., Evans J. M., Faruk E. A., Hamilton T. C., Nash D. J., Stemp G., Willcocks K. Synthesis and antihypertensive activity of 4-(cyclic amido)-2H-1-benzopyrans. J Med Chem. 1986 Nov;29(11):2194–2201. doi: 10.1021/jm00161a011. [DOI] [PubMed] [Google Scholar]
  3. Buckingham R. E., Clapham J. C., Hamilton T. C., Longman S. D., Norton J., Poyser R. H. BRL 34915, a novel antihypertensive agent: comparison of effects on blood pressure and other haemodynamic parameters with those of nifedipine in animal models. J Cardiovasc Pharmacol. 1986 Jul-Aug;8(4):798–804. doi: 10.1097/00005344-198709010-00022. [DOI] [PubMed] [Google Scholar]
  4. Buckingham R. E., Hamilton T. C., Howlett D. R., Mootoo S., Wilson C. Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat. Br J Pharmacol. 1989 May;97(1):57–64. doi: 10.1111/j.1476-5381.1989.tb11923.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Buckingham R. E. Studies on the anti-vasoconstrictor activity of BRL 34915 in spontaneously hypertensive rats; a comparison with nifedipine. Br J Pharmacol. 1988 Mar;93(3):541–552. doi: 10.1111/j.1476-5381.1988.tb10309.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cavero I., Mondot S., Mestre M. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels. J Pharmacol Exp Ther. 1989 Mar;248(3):1261–1268. [PubMed] [Google Scholar]
  7. Coldwell M. C., Howlett D. R. Specificity of action of the novel antihypertensive agent, BRL 34915, as a potassium channel activator. Comparison with nicorandil. Biochem Pharmacol. 1987 Nov 1;36(21):3663–3669. doi: 10.1016/0006-2952(87)90017-7. [DOI] [PubMed] [Google Scholar]
  8. Cook N. S. The pharmacology of potassium channels and their therapeutic potential. Trends Pharmacol Sci. 1988 Jan;9(1):21–28. doi: 10.1016/0165-6147(88)90238-6. [DOI] [PubMed] [Google Scholar]
  9. Dunne M. J., Aspinall R. J., Petersen O. H. The effects of cromakalim on ATP-sensitive potassium channels in insulin-secreting cells. Br J Pharmacol. 1990 Jan;99(1):169–175. doi: 10.1111/j.1476-5381.1990.tb14672.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Dunning B. E., Ahren B., Veith R. C., Böttcher G., Sundler F., Taborsky G. J., Jr Galanin: a novel pancreatic neuropeptide. Am J Physiol. 1986 Jul;251(1 Pt 1):E127–E133. doi: 10.1152/ajpendo.1986.251.1.E127. [DOI] [PubMed] [Google Scholar]
  11. Escande D., Thuringer D., Leguern S., Cavero I. The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytes. Biochem Biophys Res Commun. 1988 Jul 29;154(2):620–625. doi: 10.1016/0006-291x(88)90184-2. [DOI] [PubMed] [Google Scholar]
  12. Foster C. D., Fujii K., Kingdon J., Brading A. F. The effect of cromakalim on the smooth muscle of the guinea-pig urinary bladder. Br J Pharmacol. 1989 May;97(1):281–291. doi: 10.1111/j.1476-5381.1989.tb11952.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Gillespie J. S., Sheng H. The lack of involvement of cyclic nucleotides in the smooth muscle relaxant action of BRL 34915. Br J Pharmacol. 1988 Aug;94(4):1189–1197. doi: 10.1111/j.1476-5381.1988.tb11638.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hamilton T. C., Weir S. W., Weston A. H. Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal vein. Br J Pharmacol. 1986 May;88(1):103–111. doi: 10.1111/j.1476-5381.1986.tb09476.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hamilton T. C., Weston A. H. Cromakalim, nicorandil and pinacidil: novel drugs which open potassium channels in smooth muscle. Gen Pharmacol. 1989;20(1):1–9. doi: 10.1016/0306-3623(89)90052-9. [DOI] [PubMed] [Google Scholar]
  16. Henquin J. C., Meissner H. P. Opposite effects of tolbutamide and diazoxide on 86Rb+ fluxes and membrane potential in pancreatic B cells. Biochem Pharmacol. 1982 Apr 1;31(7):1407–1415. doi: 10.1016/0006-2952(82)90036-3. [DOI] [PubMed] [Google Scholar]
  17. Holzmann S. Cyclic GMP as possible mediator of coronary arterial relaxation by nicorandil (SG-75). J Cardiovasc Pharmacol. 1983 May-Jun;5(3):364–370. doi: 10.1097/00005344-198305000-00004. [DOI] [PubMed] [Google Scholar]
  18. Ito M., Baba K., Takagi K., Satake T., Tomita T. Effects of high K on relaxation produced by drugs in the guinea-pig tracheal muscle. Respir Physiol. 1985 Jul;61(1):43–55. doi: 10.1016/0034-5687(85)90027-1. [DOI] [PubMed] [Google Scholar]
  19. Johnson G. A., Barsuhn K. J., McCall J. M. Sulfation of minoxidil by liver sulfotransferase. Biochem Pharmacol. 1982 Sep 15;31(18):2949–2954. doi: 10.1016/0006-2952(82)90268-4. [DOI] [PubMed] [Google Scholar]
  20. Kauffman R. F., Schenck K. W., Conery B. G., Cohen M. L. Effects of pinacidil on serotonin-induced contractions and cyclic nucleotide levels in isolated rat aortae: comparison with nitroglycerin, minoxidil, and hydralazine. J Cardiovasc Pharmacol. 1986 Nov-Dec;8(6):1195–1200. doi: 10.1097/00005344-198611000-00015. [DOI] [PubMed] [Google Scholar]
  21. Leblanc N., Wilde D. W., Keef K. D., Hume J. R. Electrophysiological mechanisms of minoxidil sulfate-induced vasodilation of rabbit portal vein. Circ Res. 1989 Oct;65(4):1102–1111. doi: 10.1161/01.res.65.4.1102. [DOI] [PubMed] [Google Scholar]
  22. Loubatières A., Mariani M. M., Alric R. The action of diazoxide on insulin secretion, medullo-adrenal secretion, and the liberation of catecholamines. Ann N Y Acad Sci. 1968 Apr 11;150(2):226–241. doi: 10.1111/j.1749-6632.1968.tb19048.x. [DOI] [PubMed] [Google Scholar]
  23. Meisheri K. D., Cipkus L. A., Taylor C. J. Mechanism of action of minoxidil sulfate-induced vasodilation: a role for increased K+ permeability. J Pharmacol Exp Ther. 1988 Jun;245(3):751–760. [PubMed] [Google Scholar]
  24. Okabe K., Kajioka S., Nakao K., Kitamura K., Kuriyama H., Weston A. H. Actions of cromakalim on ionic currents recorded from single smooth muscle cells of the rat portal vein. J Pharmacol Exp Ther. 1990 Feb;252(2):832–839. [PubMed] [Google Scholar]
  25. Osterrieder W. Modification of K+ conductance of heart cell membrane by BRL 34915. Naunyn Schmiedebergs Arch Pharmacol. 1988 Jan;337(1):93–97. doi: 10.1007/BF00169483. [DOI] [PubMed] [Google Scholar]
  26. Quast U., Baumlin Y. Comparison of the effluxes of 42K+ and 86Rb+ elicited by cromakalim (BRL 34915) in tonic and phasic vascular tissue. Naunyn Schmiedebergs Arch Pharmacol. 1988 Sep;338(3):319–326. doi: 10.1007/BF00173407. [DOI] [PubMed] [Google Scholar]
  27. RUBIN A. A., ROTH F. E., TAYLOR R. M., ROSENKILDE H. Pharmacology of diazoxide, an antihypertensive, nondiuretic benzothiadiazine. J Pharmacol Exp Ther. 1962 Jun;136:344–352. [PubMed] [Google Scholar]
  28. Rhodes H. J., Sutter M. C. The action of diazoxide on isolated vascular smooth muscle electrophysiology and contraction. Can J Physiol Pharmacol. 1971 Apr;49(4):267–287. [PubMed] [Google Scholar]
  29. Schmid-Antomarchi H., De Weille J., Fosset M., Lazdunski M. The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells. J Biol Chem. 1987 Nov 25;262(33):15840–15844. [PubMed] [Google Scholar]
  30. Smith J. M., Sanchez A. A., Jones A. W. Comparison of rubidium-86 and potassium-42 fluxes in rat aorta. Blood Vessels. 1986;23(6):297–309. doi: 10.1159/000158657. [DOI] [PubMed] [Google Scholar]
  31. Southerton J. S., Weston A. H., Bray K. M., Newgreen D. T., Taylor S. G. The potassium channel opening action of pinacidil; studies using biochemical, ion flux and microelectrode techniques. Naunyn Schmiedebergs Arch Pharmacol. 1988 Sep;338(3):310–318. doi: 10.1007/BF00173406. [DOI] [PubMed] [Google Scholar]
  32. Standen N. B., Quayle J. M., Davies N. W., Brayden J. E., Huang Y., Nelson M. T. Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle. Science. 1989 Jul 14;245(4914):177–180. doi: 10.1126/science.2501869. [DOI] [PubMed] [Google Scholar]
  33. Sturgess N. C., Kozlowski R. Z., Carrington C. A., Hales C. N., Ashford M. L. Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line. Br J Pharmacol. 1988 Sep;95(1):83–94. doi: 10.1111/j.1476-5381.1988.tb16551.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Thorens S., Haeusler G. Effects of some vasodilators on calcium translocation in intact and fractionated vascular smooth muscle. Eur J Pharmacol. 1979 Feb 15;54(1-2):79–91. doi: 10.1016/0014-2999(79)90410-2. [DOI] [PubMed] [Google Scholar]
  35. Trube G., Rorsman P., Ohno-Shosaku T. Opposite effects of tolbutamide and diazoxide on the ATP-dependent K+ channel in mouse pancreatic beta-cells. Pflugers Arch. 1986 Nov;407(5):493–499. doi: 10.1007/BF00657506. [DOI] [PubMed] [Google Scholar]
  36. Videbaek L. M., Aalkjaer C., Mulvany M. J. Pinacidil opens K+-selective channels causing hyperpolarization and relaxation of noradrenaline contractions in rat mesenteric resistance vessels. Br J Pharmacol. 1988 Sep;95(1):103–108. doi: 10.1111/j.1476-5381.1988.tb16553.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Wales J. K., Grant A. M., Wolff F. W. Reversal of diazoxide effects by tolbutamide. Lancet. 1967 May 27;1(7500):1137–1138. doi: 10.1016/s0140-6736(67)91711-4. [DOI] [PubMed] [Google Scholar]
  38. Weir S. W., Weston A. H. The effects of BRL 34915 and nicorandil on electrical and mechanical activity and on 86Rb efflux in rat blood vessels. Br J Pharmacol. 1986 May;88(1):121–128. doi: 10.1111/j.1476-5381.1986.tb09478.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Winquist R. J., Heaney L. A., Wallace A. A., Baskin E. P., Stein R. B., Garcia M. L., Kaczorowski G. J. Glyburide blocks the relaxation response to BRL 34915 (cromakalim), minoxidil sulfate and diazoxide in vascular smooth muscle. J Pharmacol Exp Ther. 1989 Jan;248(1):149–156. [PubMed] [Google Scholar]
  40. Zünkler B. J., Lenzen S., Männer K., Panten U., Trube G. Concentration-dependent effects of tolbutamide, meglitinide, glipizide, glibenclamide and diazoxide on ATP-regulated K+ currents in pancreatic B-cells. Naunyn Schmiedebergs Arch Pharmacol. 1988 Feb;337(2):225–230. doi: 10.1007/BF00169252. [DOI] [PubMed] [Google Scholar]
  41. de Weille J., Schmid-Antomarchi H., Fosset M., Lazdunski M. ATP-sensitive K+ channels that are blocked by hypoglycemia-inducing sulfonylureas in insulin-secreting cells are activated by galanin, a hyperglycemia-inducing hormone. Proc Natl Acad Sci U S A. 1988 Feb;85(4):1312–1316. doi: 10.1073/pnas.85.4.1312. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES